kaiser semaglutide reddit California is ending coverage for weight loss drugs, despite TrumpRx Telehealth booms on surging GLP-1

A randomized clinical trial published in May 2026 in The Lancet investigated whether semaglutide, a GLP-1 peptide that acts as a GLP-1 receptor agonist and is approved for obesity treatment, was associated with changes in alcohol consumption among adults living with both obesity and alcohol use disorder

Neuroendocrinology 83 (56), 360370 (2006).doi: 10.1159/000095548

C., Schoenfeld, D

The pink states are those where Novo Nordisk and Eli Lilly have filed lawsuits

Key contraindications and safety precautions that you should be aware of are: It is generally considered unsafe during pregnancy and breastfeeding because it can increase the risk of serious problems such as Neonatal Jaundice

In comparison, someone tapering off completely might use even smaller, non standard amounts, such as 0.125 mg weekly, which is not part of approved dosing guidelines and would require manual adjustment